Viatris (VTRS) insider buying and selling
Every Table I transaction reported by directors and officers of S&P 500 companies on SEC Form 4 filings (2 business days to file): each row labeled with its official transaction code, nothing filtered out beforehand.
Open-market purchases (code P) are the rare signal, in green; sales (code S) are common and often pre-scheduled (10b5-1). Table II (derivatives) is not included: its prices are exercise prices, not market values. Guide: insider buying.
| Date | Ticker | Insider | Role | Shares | Price | Amount | % of stake | Type / filing |
|---|
Download these transactions as CSV No account, no sign-up. The data is public: it comes from SEC Form 4 filings.
Viatris Inc. (VTRS) insider buying and selling: 2 purchases, 3 sales
51 Form 4 Table I transactions filed with the SEC by Viatris Inc. insiders between 2025-09-12 and 2026-08-18 (15-month history): 2 open-market purchases and 3 sales, plus 46 transactions under other Form 4 codes, broken down one by one below. The largest open-market trade is a sale of $810k by Campbell Paul on 2026-06-25.
Viatris insider buying and selling over the last 12 months
Between Oct 21, 2025 and Oct 20, 2026, Viatris insiders filed 1 purchase worth $2k and 2 sales worth $1.1M on the open market. The net balance is on the sell side: $1.1M more sold than bought.
The biggest buyer was Simmons David S (Director): $2k in 1 purchase, the only buyer. The biggest seller was Campbell Paul (See Remarks): $1.1M in 2 sales, the only seller.
The largest trade of the period was a sale of $810k on Jun 25, 2026, by Campbell Paul (See Remarks), under a 10b5-1 plan. Form 4 on sec.gov (0001140361-26-026593).
Of the 2 sales, 1 (50%, $810k) carries the 10b5-1 plan flag on the Form 4, meaning it was scheduled months ahead; the other one does not.
The last three months show 0 purchases and 0 sales, against 0 and 1 in the three before. The latest purchase is from Nov 3, 2025; the latest sale from Jun 25, 2026.
Against its sector (Healthcare, 59 companies with an insider page on this site), over the same dates the median is 9 sales and 0 purchases on the open market. Viatris has more sales than 8 of the other 58, ranks 47 of 59 by net dollars sold, and 19 of the 59 have at least one purchase, Viatris included.
The 20 most important trades
The 2 open-market purchases first, then the rest, each type from largest to smallest. The full history is in the tool above, already searched.
See all 51 VTRS trades in the full history →
| Trade date | Filed | Insider | Role | Amount | Code | Filing |
|---|---|---|---|---|---|---|
| 2025-08-27 | 2026-03-10 | Simmons David S | Director | $3k | P — Open-market purchase Indirect holding, through: By Family Trusts 2 Form 4 footnotesF1 These shares were acquired by the reporting person's investment advisors in managed accounts as part of the investment advisors' implementation and continued execution of managed investment strategies to mirror certain index funds involving the securities of multiple issuers. F2 Based on information provided by the investment advisor; additional information, including the price range, if any, is unavailable. | SEC |
| 2025-11-03 | 2026-03-10 | Simmons David S | Director | $2k | P — Open-market purchase Indirect holding, through: By Family Trusts 3 Form 4 footnotesF1 These shares were acquired by the reporting person's investment advisors in managed accounts as part of the investment advisors' implementation and continued execution of managed investment strategies to mirror certain index funds involving the securities of multiple issuers. F2 Based on information provided by the investment advisor; additional information, including the price range, if any, is unavailable. F3 These shares are held in family trusts for which the reporting person or his spouse serve as trustee: (i) 13 shares in a trust for the benefit of the reporting person for which the reporting person serves as trustee; (ii) 63 shares in a trust for the benefit of the reporting person and his children for which the reporting person serves as trustee; (iii) 522 shares in a trust for the benefit of the reporting person's spouse for which the reporting person's spouse serves as trustee; and (iv) 585 shares in trusts for the benefit of the reporting person's children for which the reporting person's spouse serves as trustee. | SEC |
| 2026-06-25 | 2026-06-26 | Campbell Paul | See Remarks | $810k | S — Open-market sale (scheduled 10b5-1)2 Form 4 footnotesF1 These shares of common stock were sold pursuant to a written plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended, that was adopted by the reporting person on March 24, 2026. F2 Represents the weighted average price of the reporting person's disposition of 50,076 shares of common stock in transactions ranging from $15.979 to $16.31. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares of common stock sold at each separate price within the range set forth in this footnote. | SEC |
| 2026-03-23 | 2026-03-24 | Campbell Paul | See Remarks | $284k | S — Open-market saleForm 4 footnoteF1 Represents the weighted average price of the reporting person's disposition of 21,350 shares of common stock in transactions ranging from $13.205 to $13.34. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares of common stock sold at each separate price within the range set forth in this footnote. | SEC |
| 2025-09-11 | 2025-09-12 | Le Goff Corinne | Chief Commercial Officer | $72k | S — Open-market sale (scheduled 10b5-1)2 Form 4 footnotesF1 These shares of common stock were sold pursuant to a written plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended, that was adopted by the reporting person on June 12, 2025. F2 Represents the weighted average price of the reporting person's disposition of 7,032 shares of common stock in transactions ranging from $10.2289 to $10.25. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares of common stock sold at each separate price within the range set forth in this footnote. | SEC |
| 2026-03-03 | 2026-03-05 | Smith Scott Andrew | Chief Executive Officer | $8.4M | F — Tax withholding (shares surrendered for taxes)3 Form 4 footnotesF1 Represents withholding of shares of common stock for the tax liability associated with the vesting and settlement of a portion of the restricted stock units (RSUs) granted on April 1, 2023. F3 Represents withholding of shares of common stock for the tax liability associated with the vesting and settlement of a portion of the dividend equivalent units (DEUs) that accrued with respect to the RSUs previously granted on April 1, 2023. F4 Represents withholding of shares of common stock for the tax liability associated with the vesting and settlement of the performance restricted stock units (PRSUs) granted on April 1, 2023. | SEC |
| 2026-03-03 | 2026-03-05 | Campbell Paul | See Remarks | $1.2M | F — Tax withholding (shares surrendered for taxes)3 Form 4 footnotesF1 Represents withholding of shares of common stock for the tax liability associated with the vesting and settlement of a portion of the restricted stock units (RSUs) granted on March 3, 2023. F3 Represents withholding of shares of common stock for the tax liability associated with the vesting and settlement of a portion of the dividend equivalent units (DEUs) that accrued with respect to the RSUs previously granted on March 3, 2023. F4 Represents withholding of shares of common stock for the tax liability associated with the vesting and settlement of the performance restricted stock units (PRSUs) granted on March 3, 2023. | SEC |
| 2026-03-03 | 2026-03-05 | Enrietti Andrew | See Remarks | $803k | F — Tax withholding (shares surrendered for taxes)3 Form 4 footnotesF1 Represents withholding of shares of common stock for the tax liability associated with the vesting and settlement of a portion of the restricted stock units (RSUs) granted on March 3, 2023. F3 Represents withholding of shares of common stock for the tax liability associated with the vesting and settlement of a portion of the dividend equivalent units (DEUs) that accrued with respect to the RSUs previously granted on March 3, 2023. F4 Represents withholding of shares of common stock for the tax liability associated with the vesting and settlement of the performance restricted stock units (PRSUs) granted on March 3, 2023. | SEC |
| 2026-03-06 | 2026-03-10 | Smith Scott Andrew | Chief Executive Officer | $728k | F — Tax withholding (shares surrendered for taxes)2 Form 4 footnotesF1 Represents withholding of shares of common stock for the tax liability associated with the vesting and settlement of a portion of the restricted stock units (RSUs) granted on March 6, 2025. F3 Represents withholding of shares of common stock for the tax liability associated with the vesting and settlement of a portion of the dividend equivalent units (DEUs) that accrued with respect to the RSUs previously granted on March 6, 2025. | SEC |
| 2026-03-04 | 2026-03-05 | Smith Scott Andrew | Chief Executive Officer | $586k | F — Tax withholding (shares surrendered for taxes)2 Form 4 footnotesF5 Represents withholding of shares of common stock for the tax liability associated with the vesting and settlement of a portion of the RSUs granted on March 4, 2024. F7 Represents withholding of shares of common stock for the tax liability associated with the vesting and settlement of a portion of the DEUs that accrued with respect to the RSUs previously granted on March 4, 2024. | SEC |
| 2026-03-06 | 2026-03-10 | Mistras Theodora | Chief Financial Officer | $343k | F — Tax withholding (shares surrendered for taxes)2 Form 4 footnotesF1 Represents withholding of shares of common stock for the tax liability associated with the vesting and settlement of a portion of the restricted stock units (RSUs) granted on March 6, 2025. F3 Represents withholding of shares of common stock for the tax liability associated with the vesting and settlement of a portion of the dividend equivalent units (DEUs) that accrued with respect to the RSUs previously granted on March 6, 2025. | SEC |
| 2026-03-06 | 2026-03-10 | Le Goff Corinne | Chief Commercial Officer | $291k | F — Tax withholding (shares surrendered for taxes)2 Form 4 footnotesF1 Represents withholding of shares of common stock for the tax liability associated with the vesting and settlement of a portion of the restricted stock units (RSUs) granted on March 6, 2025. F3 Represents withholding of shares of common stock for the tax liability associated with the vesting and settlement of a portion of the dividend equivalent units (DEUs) that accrued with respect to the RSUs previously granted on March 6, 2025. | SEC |
| 2026-03-04 | 2026-03-05 | Mistras Theodora | Chief Financial Officer | $277k | F — Tax withholding (shares surrendered for taxes)2 Form 4 footnotesF1 Represents withholding of shares of common stock for the tax liability associated with the vesting and settlement of a portion of the restricted stock units (RSUs) granted on March 4, 2024. F3 Represents withholding of shares of common stock for the tax liability associated with the vesting and settlement of a portion of the dividend equivalent units (DEUs) that accrued with respect to the RSUs previously granted on March 4, 2024. | SEC |
| 2026-04-15 | 2026-04-16 | Le Goff Corinne | Chief Commercial Officer | $264k | F — Tax withholding (shares surrendered for taxes)2 Form 4 footnotesF1 Represents withholding of shares of common stock for the tax liability associated with the vesting and settlement of a portion of the restricted stock units (RSUs) granted on April 18, 2024. F3 Represents withholding of shares of common stock for the tax liability associated with the vesting and settlement of a portion of the dividend equivalent units (DEUs) that accrued with respect to the RSUs previously granted on April 18, 2024. | SEC |
| 2026-03-04 | 2026-03-05 | Le Goff Corinne | Chief Commercial Officer | $260k | F — Tax withholding (shares surrendered for taxes)2 Form 4 footnotesF1 Represents withholding of shares of common stock for the tax liability associated with the vesting and settlement of a portion of the restricted stock units (RSUs) granted on April 18, 2024. F3 Represents withholding of shares of common stock for the tax liability associated with the vesting and settlement of a portion of the dividend equivalent units (DEUs) that accrued with respect to the RSUs previously granted on April 18, 2024. | SEC |
| 2026-08-15 | 2026-08-18 | Enrietti Andrew | See Remarks | $184k | F — Tax withholding (shares surrendered for taxes)2 Form 4 footnotesF1 Represents withholding of shares of common stock for the tax liability associated with the vesting and settlement of a portion of the restricted stock units (RSUs) granted on August 15, 2025. F3 Represents withholding of shares of common stock for the tax liability associated with the vesting and settlement of a portion of the dividend equivalent units (DEUs) that accrued with respect to the RSUs previously granted on August 15, 2025. | SEC |
| 2026-01-01 | 2026-01-02 | Mistras Theodora | Chief Financial Officer | $182k | F — Tax withholding (shares surrendered for taxes)2 Form 4 footnotesF1 Represents withholding of shares of common stock for the tax liability associated with the vesting and settlement of a portion of the restricted stock units (RSUs) granted on January 1, 2024. F3 Represents withholding of shares of common stock for the tax liability associated with the vesting and settlement of a portion of the dividend equivalent units (DEUs) that accrued with respect to the RSUs previously granted on January 1, 2024. | SEC |
| 2026-03-06 | 2026-03-10 | Campbell Paul | See Remarks | $180k | F — Tax withholding (shares surrendered for taxes)2 Form 4 footnotesF1 Represents withholding of shares of common stock for the tax liability associated with the vesting and settlement of a portion of the restricted stock units (RSUs) granted on March 6, 2025. F3 Represents withholding of shares of common stock for the tax liability associated with the vesting and settlement of a portion of the dividend equivalent units (DEUs) that accrued with respect to the RSUs previously granted on March 6, 2025. | SEC |
| 2026-03-06 | 2026-03-10 | Enrietti Andrew | See Remarks | $124k | F — Tax withholding (shares surrendered for taxes)2 Form 4 footnotesF1 Represents withholding of shares of common stock for the tax liability associated with the vesting and settlement of a portion of the restricted stock units (RSUs) granted on March 6, 2025. F3 Represents withholding of shares of common stock for the tax liability associated with the vesting and settlement of a portion of the dividend equivalent units (DEUs) that accrued with respect to the RSUs previously granted on March 6, 2025. | SEC |
| 2026-03-04 | 2026-03-05 | Campbell Paul | See Remarks | $121k | F — Tax withholding (shares surrendered for taxes)2 Form 4 footnotesF5 Represents withholding of shares of common stock for the tax liability associated with the vesting and settlement of a portion of the RSUs granted on March 4, 2024. F7 Represents withholding of shares of common stock for the tax liability associated with the vesting and settlement of a portion of the DEUs that accrued with respect to the RSUs previously granted on March 4, 2024. | SEC |
The period balance: money in, money out
Across the Form 4 filings submitted between Sep 12, 2025 and Aug 18, 2026, Viatris Inc. open-market activity adds up to 2 purchases worth $5k and 3 sales worth $1.2M. The net balance is $1.2M on the sell side.
Only codes P and S count, where an insider puts in or takes out their own money. A selling balance like Viatris Inc.'s is the norm in the S&P 500, where much of the pay comes as stock. It is not a recommendation to buy or sell: it is what was filed.
Every transaction, code by code
| Code | What it means | Trades | Reported amount |
|---|---|---|---|
| M | Option exercise | 26 | $0 |
| F | Tax withholding (shares surrendered for taxes) | 17 | $14.1M |
| S | Open-market sale | 3 | $1.2M |
| X | In-the-money option exercise | 3 | $0 |
| P | Open-market purchase | 2 | $5k |
| Total | Everything filed in the period | 51 | $15.3M |
29 of the 51 rows carry no usable amount on the Form 4: they count as trades and add $0. The code labels come from the SEC index.
Who has traded
Over the 15 months of history, 17 distinct people or entities have filed Viatris Inc. transactions: 1 bought on the open market and 2 sold. Counted by CIK, the fixed number the SEC gives each filer, and not by name, which each filer types their own way.
| Filer | Role | Transactions | Bought (count) | Sold (count) | Last filed |
|---|---|---|---|---|---|
| Campbell Paul | See Remarks | 8 | — | $1.1M (2) | 2026-06-26 |
| Le Goff Corinne | Chief Commercial Officer | 7 | — | $72k (1) | 2026-04-16 |
| Simmons David S | Director | 3 | $5k (2) | — | 2026-03-10 |
| Enrietti Andrew | See Remarks | 9 | — | — | 2026-08-18 |
| Mistras Theodora | Chief Financial Officer | 6 | — | — | 2026-03-10 |
| Smith Scott Andrew | Chief Executive Officer | 6 | — | — | 2026-03-10 |
| Groothuis Leo Frans | Director | 2 | — | — | 2026-03-10 |
| Cornwell W Don | Director | 1 | — | — | 2026-03-10 |
Shown here are the 8 who moved the most money, out of 17. The rest are in the full history, one link above. The name links to all their trades, in any company. "Transactions" counts any code; the money, open market only. Role: from their latest filing.
Month by month
By the month the trade was executed, not the month it was filed; months with no trades show zero. The busiest month was Aug 2025: 1 purchase and 0 sales, worth $3k. 10 of the 15 months have none.
| Month | Purchases | Amount | Sales | Amount |
|---|---|---|---|---|
| Aug 2025 | 1 | $3k | 0 | $0 |
| Sep 2025 | 0 | $0 | 1 | $72k |
| Oct 2025 | 0 | $0 | 0 | $0 |
| Nov 2025 | 1 | $2k | 0 | $0 |
| Dec 2025 | 0 | $0 | 0 | $0 |
| Jan 2026 | 0 | $0 | 0 | $0 |
| Feb 2026 | 0 | $0 | 0 | $0 |
| Mar 2026 | 0 | $0 | 1 | $284k |
| Apr 2026 | 0 | $0 | 0 | $0 |
| May 2026 | 0 | $0 | 0 | $0 |
| Jun 2026 | 0 | $0 | 1 | $810k |
| Jul 2026 | 0 | $0 | 0 | $0 |
| Aug 2026 | 0 | $0 | 0 | $0 |
| Sep 2026 | 0 | $0 | 0 | $0 |
| Oct 2026 | 0 | $0 | 0 | $0 |
The last month may be partial: a Form 4 is filed up to two business days later. The table does not say whether the pattern is good or bad; it says when it happened.
Viatris Inc. (VTRS) analysis page →
Other Healthcare companies with insider trades
All 500 are listed in the section index →
Which insiders are buying their own company stock →
How to read this data
2 of the 3 sales in the table are flagged as scheduled (10b5-1 plan): signed months ahead and executed automatically, so they say nothing about what the insider thinks today. Viatris's 2 open-market purchases (code P) are the rare signal: insiders are already paid in stock, so buying more means putting in their own money. The latest filing is from Aug 18, 2026, and a Form 4 arrives up to two business days after the trade.
20 of the 20 rows in the table carry footnotes from the Form 4 itself, folded into the code column and copied verbatim; a row with no footnote means the filing has none.
Guide: Insider buying · all guides
What is behind these trades
The concepts on this page, explained from scratch in the Academy. Free, no account.
- What the efficiency hypothesis says and what it does NOT sayIf an insider's purchase is public and anyone can read it, is there any information left in it? That is the exact question that brings people here.
- Who really moves the market: the types of investorWho sits on the other side of each order, and where a company's own insiders fit among them.
- Supply, demand and price: why it rises and falls constantlyHow a piece of news ends up inside the price, and why the reaction to a filed sale is rarely the one you would expect.
Source: SEC EDGAR Form 4. This is a list of public facts, not financial advice or a recommendation to buy or sell.